Highlights
NASDAQ: CLLS       Cellectis S.A. ADR
Last Price Today's Change   Day's Range   Trading Volume
13.53   -0.16 (1.17%)  13.33 - 13.70  88,900

Overview

 
Avg Volume (4 weeks):107,660
4 Weeks Range:9.90 - 13.98
4 Weeks Price Volatility (%):
88.97%
52 Weeks Range:9.50 - 22.66
52 Weeks Price Volatility (%):
30.62%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body’s immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company’s gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. The company reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers